Meta-Analysis of Serum Gastrin-Releasing Peptide Precursor as a Biomarker for Diagnosis of Small Cell Lung Cancer

about

Pro-gastrin-releasing peptide (ProGRP) as a biomarker in small-cell lung cancer diagnosis, monitoring and evaluation of treatment response.

P2860

Q47159086-3013640D-377B-4CF9-A9C2-C5875CCA4D78

P2860

Meta-Analysis of Serum Gastrin-Releasing Peptide Precursor as a Biomarker for Diagnosis of Small Cell Lung Cancer

Item

http://www.wikidata.org/entity/Q42143975

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Meta-Analysis of Serum Gastrin ...... osis of Small Cell Lung Cancer

@en

Meta-Analysis of Serum Gastrin ...... osis of Small Cell Lung Cancer

@nl

type

Item

label

Meta-Analysis of Serum Gastrin ...... osis of Small Cell Lung Cancer

@en

Meta-Analysis of Serum Gastrin ...... osis of Small Cell Lung Cancer

@nl

prefLabel

Meta-Analysis of Serum Gastrin ...... osis of Small Cell Lung Cancer

@en

Meta-Analysis of Serum Gastrin ...... osis of Small Cell Lung Cancer

@nl

P1476

Meta-Analysis of Serum Gastrin ...... osis of Small Cell Lung Cancer

@en

P2093

Fei Wang

http://www.w3.org/2001/XMLSchema#string

Hu Ma

http://www.w3.org/2001/XMLSchema#string

Jian Guo Zhou

http://www.w3.org/2001/XMLSchema#string

Lang Huang

http://www.w3.org/2001/XMLSchema#string

Shui Ping Lv

http://www.w3.org/2001/XMLSchema#string

Yi Wang

http://www.w3.org/2001/XMLSchema#string

P2860

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies

Cancer statistics, 2016

The diagnostic odds ratio: a single indicator of test performance.

A gastrin releasing peptide from the porcine nonantral gastric tissue.

Plasma proGRP concentration is sensitive and specific for discriminating small cell lung cancer from nonmalignant conditions or non-small cell lung cancer.

ProGRP: a new biomarker for small cell lung cancer.

Pro-gastrin-releasing peptide (31-98) as a tumour marker of small-cell lung cancer: comparative evaluation with neuron-specific enolase.

New ARCHITECT plasma pro-gastrin-releasing peptide assay for diagnosing and monitoring small-cell lung cancer.

Diagnostic value of tumor marker pro-gastrin-releasing peptide in patients with small cell lung cancer: a systematic review.

Overexpression of pro-gastrin releasing peptide promotes the cell proliferation and progression in small cell lung cancer.

P304

391-397

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.22034/APJCP.2017.18.2.391

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28345820

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

5454733

http://www.w3.org/2001/XMLSchema#string

Meta-Analysis of Serum Gastrin-Releasing Peptide Precursor as a Biomarker for Diagnosis of Small Cell Lung Cancer

about

P2860

P2860

Meta-Analysis of Serum Gastrin-Releasing Peptide Precursor as a Biomarker for Diagnosis of Small Cell Lung Cancer

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932